Ducab, a leading UAE-based end-to-end energy solutions provider and manufacturer of high-quality cables and wires, has marked ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

Median progression-free survival (mPFS) was 15.1 months, and the confirmed overall response rate (cORR) increased to 45% for the 100mg QD (once daily) tablet cohort in an updated analysis of the ...

Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA, ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

However, a Nepra official claimed that the financial impact of the incremental consumption package during the second quarter of the current fiscal year stood at Rs 7.519 billion. The official added ...

A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.

Weight loss is a well-recognized but poorly understood non-motor feature of Parkinson's disease (PD). Many patients progressively lose weight as the disease advances, often alongside worsening motor ...

Weight loss is a well-recognized but poorly understood non-motor feature of Parkinson's disease (PD). Many patients ...

The City of Branson’s Board of Aldermen Tuesday heard hours of public comments ahead of a unanimous vote to approve what’s ...

Lycopene may reduce the risk of severe periodontitis in non-Hispanic White (NHW) older adults. | Drug Discovery And ...